-
Recent U.S. seafood recalls involve shrimp contaminated with Cesium-137, a radioactive isotope. The FDA reports contamination in imported shrimp from Indonesia, linked to unsanitary storage conditions. No illnesses have been reported, but health risks remain. Authorities continue investigations as recalls expand.
-
Florida's health department announced plans to eliminate all vaccine mandates for schoolchildren, led by Surgeon General Joseph Ladapo. The move, supported by Governor Ron DeSantis, frames mandates as an infringement on personal rights, despite public health research showing vaccines' effectiveness. Critics warn of potential disease outbreaks.
-
On October 10, 2025, President Donald Trump announced a deal with AstraZeneca to lower drug prices for Medicaid patients by matching the lowest prices in developed countries. The agreement includes AstraZeneca's commitment to invest $50 billion in U.S. manufacturing by 2030 and participation in the upcoming TrumpRx website, which will sell discounted drugs directly to consumers starting in early 2026.
-
Tyson Foods announced it will remove high-fructose corn syrup, sucralose, BHA/BHT, and titanium dioxide from its products by the end of 2025. The move aligns with broader efforts to improve food safety and health, amid ongoing debates over additive safety and regulatory standards in the US and UK.
-
Recent CDC advisory panel declined to recommend COVID-19 vaccines for any age group this fall, leaving vaccination decisions to individuals and healthcare providers. The move follows FDA restrictions limiting vaccine access and reflects shifting attitudes amid ongoing debates about vaccine safety and policy. The decision impacts vaccine coverage and public trust.
-
Indonesia's seafood and spice exports to the US are under scrutiny after radioactive cesium-137 was detected in shipments of shrimp and cloves. Authorities have suspended some exports, traced contamination sources to scrap metal, and are implementing safety measures. The contamination levels are low but raise health and trade concerns.
-
As of early October 2025, the Stratus COVID-19 variant (XFG and XFG.3) has become dominant in the US, causing persistent respiratory symptoms but no increased severity. Meanwhile, Japan faces an unusually early and rapid influenza epidemic, with hospitals filling and schools closing. Experts urge vaccination and hygiene to mitigate these overlapping respiratory threats.
-
The FDA has approved remibrutinib, marketed as Rhapsido, for adults with chronic spontaneous urticaria, a condition affecting sleep, work, and mental health. This marks a new treatment option, expanding the therapeutic landscape for this non-life-threatening but impactful condition.
-
PepsiCo announced plans to eliminate artificial colors and flavors from its products, including Doritos and Mountain Dew, over several years. The move aligns with FDA efforts to ban synthetic dyes like Red 40 and Yellow 5, amid concerns over health impacts. Initial product changes are expected later this year and early next year.
-
The FDA approved a low-cost generic form of mifepristone, a drug used for early pregnancy termination, despite ongoing safety reviews and political criticism. The decision has sparked debate over drug safety, regulatory processes, and abortion access, with opponents calling the move reckless and proponents emphasizing safety data.
-
Dubai-style chocolate bars, known for their thick texture and exotic fillings like pistachio and tahini, have surged in global popularity since 2021. Major retailers and restaurants worldwide now offer variations, fueling demand and causing a pistachio shortage. The trend reflects a growing appetite for indulgent, textured confections blending luxury and novelty as of late October 2025.
-
Recent articles highlight new non-invasive hair regrowth treatments like FDA-cleared laser devices, alongside ongoing concerns about health risks from hair dye, especially among celebrity fans. The stories cover technological innovations, cultural trends, and health implications, emphasizing informed choices in hair care.
-
Nate's Fine Foods of Roseville, California, recalled thousands of pasta cases after tests linked their products to a listeria outbreak that has caused four deaths and 20 illnesses since August 2024. The outbreak is connected to heat-and-eat meals produced by FreshRealm, which used the contaminated pasta. Authorities warn consumers to discard affected products.
-
Multiple infectious diseases are spreading globally, with recent outbreaks of mpox in Europe and the US, severe influenza in Hong Kong and Australia, and early flu surges in Japan. Authorities emphasize vaccination and hygiene to mitigate impacts amid evolving virus strains and rising case numbers.
-
The FDA has approved Lynkuet, a hormone-free pill from Bayer, to treat hot flashes and night sweats in menopausal women. It blocks two brain receptors affecting temperature regulation, potentially improving sleep and mood. The drug is expected to be available in November, offering an alternative to hormonal therapies with fewer risks.
-
Texas Attorney General Ken Paxton has filed a lawsuit against Johnson & Johnson and Kenvue, alleging deceptive marketing of Tylenol to pregnant women amid unproven claims linking the drug to autism. The case follows recent political statements by Trump and Kennedy suggesting a connection, which medical experts strongly dispute. The companies defend Tylenol's safety, citing scientific consensus.
-
Recent food recalls in Australia and the US are linked to Salmonella and Listeria contamination. In Australia, alfalfa sprouts from Parilla Fresh are recalled due to Salmonella, affecting several states. In the US, Nate's Fine Foods pasta caused six deaths and dozens of illnesses from Listeria. Moringa supplements were also recalled for Salmonella risk.
-
United Therapeutics announced the first successful pig kidney transplant at NYU Langone, marking a key step in xenotransplantation. The trial involved gene-edited pig kidneys and could expand if successful. Other companies are preparing similar trials amid mixed results from earlier experiments. The goal is to address organ shortages.
-
The US government ended its 43-day shutdown after Congress passed funding through January 30. Federal workers will receive back pay, and agencies are resuming operations. The shutdown caused widespread disruptions, including furloughs, service closures, and economic impacts, especially in the Washington D.C. area.
-
The NHS has approved the use of vutrisiran, a treatment for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), following NICE guidance. The drug, made by Alnylam, reduces harmful protein deposits in the heart and will be available for eligible patients in England and Wales. This marks a significant step in managing a progressive, often undiagnosed condition.